Home
Storia in 3 fonti
Novo Nordisk sues Hims & Hers over copycat weight-loss drugs
Shares in US company fall 16% after FDA announces investigation into unregulated medication
- ·
ft.com
Hims & Hers abandons copycat weight-loss drug in face of FDA probe
Novo Nordisk had accused the telehealth company of breaching its patent on Wegovy
- ·
Novo Nordisk faces more gloom from price cuts in crowded anti-obesity drugs market
Danish group’s challenges mount despite winning reprieve after Hims & Hers withdraws plan to sell copycat Wegovy pill
- ·
cnbc.com
Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill
Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.
- ·
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.
- ·
Novo Nordisk sues Hims & Hers over copycat weight-loss drugs
Shares in US company fall 16% after FDA announces investigation into unregulated medication
- ·
upi.com
Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com
Novo Nordisk, the maker of the weight loss drug Wegovy, is suing Hims & Hers for selling a cheaper version of the drug, the company announced Monday.